AAAAAA

   
Results: 1-9 |
Results: 9
Proton magnetic resonance spectroscopy (H-1-MRS) of motor cortex and basalganglia in de novo Parkinson's disease patients
Authors: Lucetti, C Del Dotto, P Gambaccini, G Bernardini, S Bianchi, MC Tosetti, M Bonuccelli, U
Citation: C. Lucetti et al., Proton magnetic resonance spectroscopy (H-1-MRS) of motor cortex and basalganglia in de novo Parkinson's disease patients, NEUROL SCI, 22(1), 2001, pp. 69-70
Cytogenetic analysis oxidative damage in lymphocytes of Parkinson's disease patients
Authors: Petrozzi, L Lucetti, C Gambaccini, G Bernardini, S Del Dotto, P Migliore, L Scarpato, R Bonuccelli, U
Citation: L. Petrozzi et al., Cytogenetic analysis oxidative damage in lymphocytes of Parkinson's disease patients, NEUROL SCI, 22(1), 2001, pp. 83-84
Intravenous amantadine improves levadopa-induced dyskinesias: An acute double-blind placebo-controlled study
Authors: Del Dotto, P Pavese, N Gambaccini, G Bernardini, S Metman, LV Chase, TN Bonuccelli, U
Citation: P. Del Dotto et al., Intravenous amantadine improves levadopa-induced dyskinesias: An acute double-blind placebo-controlled study, MOVEMENT D, 16(3), 2001, pp. 515-520
Amantadine for levodopa-induced dyskinesias
Authors: Metman, LV Del Dotto, P LePoole, K Konitsiotis, S Fang, J Chase, TN
Citation: Lv. Metman et al., Amantadine for levodopa-induced dyskinesias, NERVENHEILK, 19(5), 2000, pp. 276-279
Diurnal motor variations to repeated doses of levodopa in Parkinson's disease
Authors: Bonuccelli, U Del Dotto, P Lucetti, C Petrozzi, L Bernardini, S Gambaccini, G Rossi, G Piccini, P
Citation: U. Bonuccelli et al., Diurnal motor variations to repeated doses of levodopa in Parkinson's disease, CLIN NEUROP, 23(1), 2000, pp. 28-33
Thyroid function and autoimmunity in Parkinson's disease: a study of 101 patients
Authors: Bonuccelli, U D'Avino, C Caraccio, N Del Guerra, B Casolaro, A Pavese, N Del Dotto, P Monzani, F
Citation: U. Bonuccelli et al., Thyroid function and autoimmunity in Parkinson's disease: a study of 101 patients, PARKINS R D, 5(1-2), 1999, pp. 49-53
Pharmacokinetics and pharmacodynamics of L-DOPA after acute and 6-week tolcapone administration in patients with Parkinson's disease
Authors: Napolitano, A Del Dotto, P Petrozzi, L Dell'Agnello, G Bellini, G Gambaccini, G Bonuccelli, U
Citation: A. Napolitano et al., Pharmacokinetics and pharmacodynamics of L-DOPA after acute and 6-week tolcapone administration in patients with Parkinson's disease, CLIN NEUROP, 22(1), 1999, pp. 24-29
Amantadine for levodopa-induced dyskinesias - A 1-year follow-up study
Authors: Metman, LV Del Dotto, P LePoole, K Konitsiotis, S Fang, J Chase, TN
Citation: Lv. Metman et al., Amantadine for levodopa-induced dyskinesias - A 1-year follow-up study, ARCH NEUROL, 56(11), 1999, pp. 1383-1386
Amantadine as treatment for dyskinesias and motor fluctuations in Parkinson's disease
Authors: Metman, LV Del Dotto, P van den Munckhof, P Fang, J Mouradian, MM Chase, TN
Citation: Lv. Metman et al., Amantadine as treatment for dyskinesias and motor fluctuations in Parkinson's disease, NERVENHEILK, 17(10), 1998, pp. 480-484
Risultati: 1-9 |